Variant · Snv
PLEC NM_201384.3(PLEC):c.265-16C>G
CI-VAR-00056570Explore in graph →NM_201384.3:c.265-16C>GClinVar 384491 rs11993492
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 384491 | Benign | criteria provided, multiple submitters, no conflicts | 2 | Epidermolysis bullosa simplex with nail dystrophy; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5B, with muscular dystrophy; Epidermolysis bullosa simplex 5C, with pyloric atresia; Sarcoma; Malignant tumor of esophagus; Gastric cancer; Ovarian serous cystadenocarcinoma; Cervical cancer; Cholangiocarcinoma; Acute myeloid leukemia; Uterine corpus endometrial carcinoma; Lung cancer | germline | 6 | Feb 02, 2026 | clinvar |